Analytics Momentum RaySearch is actively expanding its oncology analytics platform with RayIntelligence v2026, signaling strong upsell and cross-sell opportunities to clinics already using RayStation and RayCare for integrated data insights and decision support.

Partnerable Growth Recent partnerships and new client onboarding, including Iridium Netwerk leveraging RayStation and RayCare with a Varian TrueBeam, indicate a market-ready ecosystem that can be leveraged to target additional clinical networks seeking seamless software integration.

Clinical Adoption A broad base of thousands of clinics globally already rely on RaySearch software, presenting a sizeable recurring revenue opportunity through expanded license usage, maintenance, and add-on modules within existing accounts.

Industry Presence Active participation in industry events like PTCOG 64 and ongoing collaboration with cancer centers position RaySearch as a thought leader, enabling targeted outreach to key decision makers at major centers and networks expanding into particle therapy.

Financial Footing With a current revenue range of ten to twenty-five million dollars and a substantial funding reserve, there is room to propose scaled deployments, pilot programs, and faster ROI-compliant implementations to accelerate adoption across mid to large clinics.